Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression

Keyphrases

• Bone Marrow 100%
• Plaque 100%
• Functional Response 100%
• Chemokine Receptor CCR2 100%
• CX3CR1 100%
• Endothelial Progenitors 100%
• Atherosclerotic Plaque Regression 100%
• CXCR2 100%
• Endothelial Progenitor Cells 60%
• Chemokine Receptor 40%
• Advanced Atherosclerosis 40%
• Atherosclerosis Regression 40%
• Mouse Model 20%
• Cell Treatment 20%
• Chemokines 20%
• Heart Stroke 20%
• Hypercholesterolemia 20%
• Pharmacological Inhibitors 20%
• Cell-mediated 20%
• Cognate Receptors 20%
• Vascular Wall 20%
• Genetic Inactivation 20%
• Intervention Effectiveness 20%
• CXCL1 20%
• Heart Attack 20%
• Lipid-lowering 20%
• Chemokine CXCL1 20%
• Chemokine CX3CL1 20%
• Plaque Regression 20%
• Paracrine Function 20%
• Support Functional 20%
• CX3CL1/CX3CR1 Axis 20%
• Arterial Plaque 20%
• Atheroregression 20%

Medicine and Dentistry

• Atherosclerosis 100%
• Chemokine Receptor CX3CR1 100%
• Chemokine Receptor CXCR2 100%
• Interleukin 8 Receptor, Beta 80%
• Endothelial Progenitor Cell 60%
• Chemokine Receptor 40%
• Myocardial Infarction 20%
• Apoplexy 20%
• Hypercholesterolemia 20%
• Chemokine 20%
• CXCL1 Chemokine 20%
• Fractalkine 20%

Immunology and Microbiology

• CX3CR1 100%
• Chemokine Receptor 100%
• Atherosclerosis 83%
• Endothelial Progenitor Cell 50%
• Mouse Model 16%
• Chemokine 16%
• CXCL1 16%
• CXCL1 Chemokine 16%
• Interleukin 8 Receptor, Beta 16%
• CX3CL1 16%
• Fractalkine 16%